한빛사논문
Moonhyuk Kwon1,2, Joseph C. Utomo1, Keunwan Park3, CameronA. Pascoe4, Sorina Chiorean4, Iris Ngo1, Kyle A. Pelot5, Cheol-Ho Pan3,6, Seon-Won Kim2, Philipp Zerbe5, John C. Vederas4, and Dae-Kyun Ro1,*
1Department of Biological Sciences, University of Calgary, 2500 University Dr. NW, Calgary, AB,T2N1N4, Canada
2Division of Applied Life Science (BK21 Four), ABC-RLRC, PMBBRC, Gyeongsang National University, Jinju, 52828, Republic of Korea
3Natural Product Informatics Research Center, Korea Institute of Science and Technology, Gangneung,25451, Republic of Korea
4Department of Chemistry, University of Alberta, 11227 Saskatchewan Dr. NW, Edmonton, AB,T6G 2G2, Canada
5Department of Plant Biology, University of California-Davis, 1 Shields Avenue, Davis, CA,95616, USA
6Department of Biological Chemistry, University ofScience and Technology (UST), Daejeon 34113, Republic of Korea
*Corresponding author
Abstract
The hallucinogenic plant, Salvia divinorum, synthesizes neoclerodane diterpenes, such as salvinorins, salvidivins, and salvinicins, which are agonistic or antagonistic to μ- or κ-opioid receptors. From S. divinorum trichomes, crotonolide G synthase (SdCS; CYP76AH39) was identified. It catalyzes the conversion of kolavenol to a dihydrofuran neoclerodane, crotonolide G. 18O2-feeding studies confirmed that SdCS incorporates an aerobic oxygen into crotonolide G, rather than forming a cation at C16 that is trapped by the alcohol at C15. Structural modeling of SdCS accompanied by site-directed mutagenesis established the importance of V367 and F479 residues in substrate-binding. The dihydrofuran neoclerodane can serve as a unique lead structure for drug development.
논문정보
관련 링크
관련분야 연구자보기
소속기관 논문보기
관련분야 논문보기
해당논문 저자보기